14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of OCUP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

On Friday, Ocuphire Pharma, Inc. stock price gained an impressive 7.57%
(Updated on May 03, 2024)

Buy or Hold candidate since May 02, 2024 Gain 7.57% PDF

The Ocuphire Pharma, Inc. stock price gained 7.57% on the last trading day (Friday, 3rd May 2024), rising from $1.85 to $1.99. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 9.68% from a day low at $1.86 to a day high of $2.04. The price has risen in 7 of the last 10 days and is up by 20.24% over the past 2 weeks. Volume fell on the last day by -312 thousand shares and in total, 350 thousand shares were bought and sold for approximately $696.99 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Given the current short-term trend, the stock is expected to fall -36.44% during the next 3 months and, with a 90% probability hold a price between $0.85 and $1.26 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

OCUP Signals & Forecast

The Ocuphire Pharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $1.69 and $1.83. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, April 22, 2024, and so far it has risen 31.79%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Ocuphire Pharma, Inc. stock

Ocuphire Pharma, Inc. finds support from accumulated volume at $1.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.180 between high and low, or 9.68%. For the last week the stock has had daily average volatility of 9.71%.

Our recommended stop-loss: $1.93 (-3.24%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (OCUP) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Ocuphire Pharma, Inc. to open at $1.96, and during the day (based on 14 day Average True Range), to move between $1.86 and $2.12, which gives a possible trading interval of +/-$0.129 (+/-6.49%) up or down from last closing price. If Ocuphire Pharma, Inc. takes out the full calculated possible swing range there will be an estimated 12.99% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.94 (2.51%) than the resistance at $2.09 (5.03%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Ocuphire Pharma, Inc. stock A Buy?

Ocuphire Pharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Ocuphire Pharma, Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$1.96 ( 1.34%) $1.99

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for OCUP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.14 7.71 %
R2 2.07 4.25 %
R1 2.03 2.12 %
Current price: 1.99
Support S1 1.89 -4.80 %
S2 1.85 -6.93 %
S3 1.78 -10.39 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.23 12.06 %
R2 2.18 9.55 %
R1 2.09 5.03 %
Current price 1.99
Support S1 1.94 -2.51%
S2 1.85 -7.04%
S3 1.84 -7.54%

FAQ

What is the symbol for Ocuphire Pharma, Inc. Stock and on which exchange is it traded?
The symbol for Ocuphire Pharma, Inc. is OCUP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ocuphire Pharma, Inc. Stock?
Ocuphire Pharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Ocuphire Pharma, Inc. Stock?
Ocuphire Pharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ocuphire Pharma, Inc. Stock.

What's the current price of Ocuphire Pharma, Inc. Stock?
As of the end of day on the May 03, 2024, the price of an Ocuphire Pharma, Inc. (OCUP) share was $1.99.

What is the 52-week high and low for Ocuphire Pharma, Inc. Stock?
The 52-week high for Ocuphire Pharma, Inc. Stock is $6.60 and the 52-week low is $1.50.

What is the market capitalization of Ocuphire Pharma, Inc. Stock?
As of the May 03, 2024, the market capitalization of Ocuphire Pharma, Inc. is 49.379M.

When is the next earnings date for Ocuphire Pharma, Inc.?
The upcoming earnings date for Ocuphire Pharma, Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Ocuphire Pharma, Inc.

Ocuphire Pharma. Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induc... OCUP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT